Mariner LLC Purchases 268,570 Shares of Haleon plc (NYSE:HLN)

Mariner LLC raised its stake in shares of Haleon plc (NYSE:HLN - Free Report) by 62.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 695,406 shares of the company's stock after acquiring an additional 268,570 shares during the period. Mariner LLC's holdings in Haleon were worth $6,634,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Synovus Financial Corp increased its position in shares of Haleon by 5.1% during the fourth quarter. Synovus Financial Corp now owns 156,467 shares of the company's stock valued at $1,493,000 after acquiring an additional 7,633 shares during the last quarter. Seeds Investor LLC increased its position in shares of Haleon by 7.7% during the 4th quarter. Seeds Investor LLC now owns 23,133 shares of the company's stock valued at $221,000 after purchasing an additional 1,648 shares during the last quarter. Rockefeller Capital Management L.P. increased its position in shares of Haleon by 3.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 95,266 shares of the company's stock valued at $909,000 after purchasing an additional 3,205 shares during the last quarter. Argent Trust Co raised its stake in shares of Haleon by 98.3% during the 4th quarter. Argent Trust Co now owns 29,880 shares of the company's stock worth $285,000 after purchasing an additional 14,809 shares during the period. Finally, Legacy Financial Advisors Inc. boosted its holdings in shares of Haleon by 13.0% in the 4th quarter. Legacy Financial Advisors Inc. now owns 23,597 shares of the company's stock worth $225,000 after buying an additional 2,720 shares during the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Stock Performance

Shares of NYSE HLN traded up $0.02 during mid-day trading on Friday, hitting $10.21. The company had a trading volume of 9,652,933 shares, compared to its average volume of 7,297,591. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon plc has a 1 year low of $8.12 and a 1 year high of $10.80. The company has a market capitalization of $46.08 billion, a price-to-earnings ratio of 30.02, a P/E/G ratio of 2.82 and a beta of 0.24. The stock's 50-day moving average price is $10.13 and its 200-day moving average price is $9.81.

Haleon (NYSE:HLN - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The business had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. On average, sell-side analysts forecast that Haleon plc will post 0.43 earnings per share for the current year.

Haleon Increases Dividend

The business also recently declared a -- dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be paid a $0.1166 dividend. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. This is a boost from Haleon's previous -- dividend of $0.05. Haleon's payout ratio is currently 58.97%.

Analyst Ratings Changes

Several analysts have commented on HLN shares. Morgan Stanley lowered shares of Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday, January 10th. Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Sanford C. Bernstein lowered Haleon from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 8th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Finally, HSBC reaffirmed a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Six research analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.